Expect Cons to Outweigh Pros for the New CAP Antibiotic Lefamulin (Xenleta)
October 2019
Lefamulin (Xenleta, zen-LEH-tah) will be the first oral and IV med in a new class of "pleuromutilin" antibiotics.
It's approved for community-acquired pneumonia (CAP) and can be used alone to cover common bugs...Strep pneumo, H. flu, and Mycoplasma.
Lefamulin is not inferior to moxifloxacin for CAP treatment. And lefamulin costs about $200/day for IV...and $280/day for tabs.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote